TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases (Q2866969): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(Added qualifier: readability score (P590521): 0.000011549083729174788) |
||||||||||||||
(One intermediate revision by the same user not shown) | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: Q2988326 (Deleted Item) / rank | |||||||||||||||
Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549083729174788
| |||||||||||||||
Property / date of last update | |||||||||||||||
| |||||||||||||||
Property / date of last update: 23 May 2023 / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
BSIM THERAPEUTICS, S.A. | |||||||||||||||
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank |
Latest revision as of 16:30, 12 March 2024
Project Q2866969 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases |
Project Q2866969 in Portugal |
Statements
24,384.33 Euro
0 references
48,768.66 Euro
0 references
50.0 percent
0 references
20 May 2017
0 references
19 May 2021
0 references
BSIM THERAPEUTICS, S.A.
0 references
Cantanhede
0 references
14 November 2023
0 references
Identifiers
CENTRO-01-0247-FEDER-028007
0 references